Medicine and Dentistry
Breast Cancer
100%
Neoplasm
56%
Breast Carcinoma
38%
Metastatic Carcinoma
21%
Recurrent Disease
21%
Neoadjuvant Chemotherapy
20%
Diseases
20%
Estrogen Receptor
17%
Immunohistochemistry
14%
Intraductal Carcinoma
13%
Lymph Node
12%
Breast Tumor
12%
Overall Survival
11%
Carcinoma
11%
Triple Negative Breast Cancer
11%
Axillary Lymph Node
11%
Malignant Neoplasm
10%
Gamma Urogastrone
9%
Mastectomy
9%
Progesterone Receptor
9%
Epidermal Growth Factor Receptor 2
9%
Biological Marker
9%
Sentinel Lymph Node
9%
Recurrence Free Survival
7%
Radiation Therapy
7%
Hormone Receptor
7%
Biopsy Technique
6%
Lymph Node Metastasis
6%
Tumor Cell
6%
Disease Free Survival
6%
Cancer Cell
6%
Primary Tumor
5%
Pathologist
5%
Cancer
5%
Lobular Carcinoma
5%
Survival Rate
5%
Doxorubicin
5%
Diagnosis
5%
Recurrence Risk
5%
Systemic Therapy
5%
Keyphrases
Breast Cancer
38%
Tumor
24%
Human Epidermal Growth Factor Receptor 2 (HER2)
20%
Breast Carcinoma
18%
Neoadjuvant Chemotherapy
15%
Breast Cancer Patients
11%
Triple-negative Breast Cancer
10%
Pathological Complete Response
10%
Estrogen Receptor
10%
Metastatic Breast Cancer
9%
Breast
9%
Ductal Carcinoma in Situ
9%
Locoregional Recurrence
8%
Overall Survival
8%
Metastasis
8%
Immunohistochemistry
7%
Chemotherapy
7%
Patients with Breast Cancer
6%
Mastectomy
6%
Early Breast Cancer
6%
Prognostic Factors
6%
Primary Breast Cancer
6%
Nuclear Grade
6%
Prognostic Significance
6%
Breast Cancer Cells
5%
Progesterone Receptor
5%
Invasive Breast Cancer
5%
Trastuzumab
5%
Invasive Breast Carcinoma
5%
Breast Reconstruction
5%
Disease-free Survival
5%
Primary Tumor
5%
Confidence Interval
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
19%
Estrogen Receptor
12%
Genomics
7%
Carcinogenesis
6%
Epidermal Growth Factor Receptor
6%
Progesterone Receptor
6%
Hormone Receptor
6%
Tumor Progression
5%
Gene Expression
5%
